131 related articles for article (PubMed ID: 25585152)
1. Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth.
Wu JB; Lin TP; Gallagher JD; Kushal S; Chung LW; Zhau HE; Olenyuk BZ; Shih JC
J Am Chem Soc; 2015 Feb; 137(6):2366-74. PubMed ID: 25585152
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugate.
Lv Q; Yang X; Wang M; Yang J; Qin Z; Kan Q; Zhang H; Wang Y; Wang D; He Z
J Control Release; 2018 Jun; 279():234-242. PubMed ID: 29679664
[TBL] [Abstract][Full Text] [Related]
3. Targeting monoamine oxidase A in advanced prostate cancer.
Flamand V; Zhao H; Peehl DM
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1761-71. PubMed ID: 20204405
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.
Xu S; Adisetiyo H; Tamura S; Grande F; Garofalo A; Roy-Burman P; Neamati N
Br J Cancer; 2015 Jul; 113(2):242-51. PubMed ID: 26103574
[TBL] [Abstract][Full Text] [Related]
5. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
[TBL] [Abstract][Full Text] [Related]
6. Repurposing antitubercular agent isoniazid for treatment of prostate cancer.
Lv Q; Wang D; Yang Z; Yang J; Zhang R; Yang X; Wang M; Wang Y
Biomater Sci; 2018 Dec; 7(1):296-306. PubMed ID: 30468220
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.
Wu JB; Shao C; Li X; Li Q; Hu P; Shi C; Li Y; Chen YT; Yin F; Liao CP; Stiles BL; Zhau HE; Shih JC; Chung LW
J Clin Invest; 2014 Jul; 124(7):2891-908. PubMed ID: 24865426
[TBL] [Abstract][Full Text] [Related]
8. MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.
Li J; Pu T; Yin L; Li Q; Liao CP; Wu BJ
Oncogene; 2020 Apr; 39(16):3305-3321. PubMed ID: 32066880
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase A (MAO A) inhibitors decrease glioma progression.
Kushal S; Wang W; Vaikari VP; Kota R; Chen K; Yeh TS; Jhaveri N; Groshen SL; Olenyuk BZ; Chen TC; Hofman FM; Shih JC
Oncotarget; 2016 Mar; 7(12):13842-53. PubMed ID: 26871599
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors⁻Indocyanine Dyes Conjugates as Targeted Antitumor Agents.
Yang XG; Mou YH; Wang YJ; Wang J; Li YY; Kong RH; Ding M; Wang D; Guo C
Molecules; 2019 Apr; 24(7):. PubMed ID: 30974737
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of a monoamine oxidase A inhibitor‑heptamethine carbocyanine dye conjugate for paclitaxel‑resistant non‑small cell lung cancer.
Yang XG; Li YY; Zhao DX; Cui W; Li H; Li XY; Li YX; Wang D
Oncol Rep; 2021 Mar; 45(3):1306-1314. PubMed ID: 33650669
[TBL] [Abstract][Full Text] [Related]
12. MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.
Lin YC; Chang YT; Campbell M; Lin TP; Pan CC; Lee HC; Shih JC; Chang PC
Sci Rep; 2017 Apr; 7():46338. PubMed ID: 28402333
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.
Li PC; Siddiqi IN; Mottok A; Loo EY; Wu CH; Cozen W; Steidl C; Shih JC
J Pathol; 2017 Oct; 243(2):220-229. PubMed ID: 28722111
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling.
Li J; Yang XM; Wang YH; Feng MX; Liu XJ; Zhang YL; Huang S; Wu Z; Xue F; Qin WX; Gu JR; Xia Q; Zhang ZG
J Hepatol; 2014 Jun; 60(6):1225-34. PubMed ID: 24607627
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase A (MAOA): A promising target for prostate cancer therapy.
Han H; Li H; Ma Y; Zhao Z; An Q; Zhao J; Shi C
Cancer Lett; 2023 Jun; 563():216188. PubMed ID: 37076041
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration.
Jacobs MR; Olivero JE; Ok Choi H; Liao CP; Kashemirov BA; Katz JE; Gross ME; McKenna CE
Bioorg Med Chem; 2023 Sep; 92():117425. PubMed ID: 37544256
[TBL] [Abstract][Full Text] [Related]
17. Monoamine Oxidase Deficiency Causes Prostate Atrophy and Reduces Prostate Progenitor Cell Activity.
Yin L; Li J; Liao CP; Jason Wu B
Stem Cells; 2018 Aug; 36(8):1249-1258. PubMed ID: 29637670
[TBL] [Abstract][Full Text] [Related]
18. MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling.
Yin L; Li J; Wang J; Pu T; Wei J; Li Q; Wu BJ
Oncogene; 2021 Feb; 40(7):1362-1374. PubMed ID: 33420365
[TBL] [Abstract][Full Text] [Related]
19. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors.
Ma J; Yoshimura M; Yamashita E; Nakagawa A; Ito A; Tsukihara T
J Mol Biol; 2004 Apr; 338(1):103-14. PubMed ID: 15050826
[TBL] [Abstract][Full Text] [Related]
20. Application of novel pH sensitive isoniazid-heptamethine carbocyanine dye conjugates against prostate cancer cells.
Yang XG; Li YF; Wang YJ; Kong RH; Wang D
Pharmazie; 2020 Sep; 75(9):412-416. PubMed ID: 32797765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]